ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,479.82
-0.54%
S&P 500
5,457.09
-0.22%
Dow Jones
39,040.25
-0.18%
US Dollar vs Yen
160.611
0.58%
Brent Oil
84.425
0.29%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Bio Rad Laboratories Inc (BIO)

  7. Bio Rad Laboratories Inc (BIO) ニュース

BIO

Bio Rad Laboratories (BIO)

Bio Rad Laboratories Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:BIO
日付受信時刻ニュースソース見出しコード企業名
2024/06/1807 : 37Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:BIOBio Rad Laboratories Inc
2024/06/1502 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BIOBio Rad Laboratories Inc
2024/06/1406 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BIOBio Rad Laboratories Inc
2024/05/3022 : 00Business WireBio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics GroupNYSE:BIOBio Rad Laboratories Inc
2024/05/2405 : 15Business WireBio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
2024/05/1005 : 30Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:BIOBio Rad Laboratories Inc
2024/05/0905 : 38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BIOBio Rad Laboratories Inc
2024/05/0905 : 31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BIOBio Rad Laboratories Inc
2024/05/0903 : 25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:BIOBio Rad Laboratories Inc
2024/05/0805 : 18Edgar (US Regulatory)Form 8-K - Current reportNYSE:BIOBio Rad Laboratories Inc
2024/05/0805 : 15Business WireBio-Rad Reports First-Quarter 2024 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
2024/05/0122 : 00Business WireBio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
2024/04/2621 : 30Business WireBio-Rad Announces Life Science Group Management ChangesNYSE:BIOBio Rad Laboratories Inc
2024/04/1822 : 00Business WireBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NYSE:BIOBio Rad Laboratories Inc
2024/04/1206 : 30GlobeNewswire Inc.Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayNYSE:BIOBio Rad Laboratories Inc
2024/04/1105 : 15Business WireBio-Rad’s Chief Operating Officer Andrew Last to RetireNYSE:BIOBio Rad Laboratories Inc
2024/03/2021 : 30Business WireBio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial OfficerNYSE:BIOBio Rad Laboratories Inc
2024/02/2306 : 30Business WireBio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access DayNYSE:BIOBio Rad Laboratories Inc
2024/02/1606 : 15Business WireBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
2024/01/2507 : 00Business WireBio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024NYSE:BIOBio Rad Laboratories Inc
2024/01/0306 : 15Business WireBio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
2023/10/2705 : 15Business WireBio-Rad Reports Third-Quarter 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
2023/10/0521 : 30Business WireBio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023NYSE:BIOBio Rad Laboratories Inc
2023/08/2905 : 15Business WireBio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare ConferenceNYSE:BIOBio Rad Laboratories Inc
2023/08/0405 : 15Business WireBio-Rad Reports Second-Quarter 2023 Financial ResultsNYSE:BIOBio Rad Laboratories Inc
2023/07/2705 : 15Business WireBio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing AgreementNYSE:BIOBio Rad Laboratories Inc
2023/07/2105 : 30Business WireBio-Rad Announces New Share Repurchase ProgramNYSE:BIOBio Rad Laboratories Inc
2023/07/1105 : 30Business WireBio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023NYSE:BIOBio Rad Laboratories Inc
2023/07/1022 : 00Business WireBio-Rad Publishes Corporate Sustainability Report for 2022NYSE:BIOBio Rad Laboratories Inc
2023/06/1606 : 13Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:BIOBio Rad Laboratories Inc
 Showing the most relevant articles for your search:NYSE:BIO

最近閲覧した銘柄

TSXV
SRES
Sun Residential Real Est...
LSE
GZ12
Citi Fun 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有